CD19 and B-cell chronic lymphocytic leukemia: Turtle and colleague enrolled 24 R/R CLL patients in a phase I/II trial where a defined composition of autologous CD4+- and CD8+ CD19-specific CAR T cells were infused following lymphodepletion.